Publications

Publications

Filter Results: (319) Arrow Down
Filter Results: (319) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 5 of 319 Results →

    Nitin Nohria

    Nitin Nohria served as the tenth dean of Harvard Business School from 2010-2020. He previously served as co-chair of the Leadership Initiative, Senior Associate Dean of Faculty Development, and Head of the Organizational Behavior unit.

    As Dean, building on... View Details

    Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
    • 15 May 2007
    • First Look

    First Look: May 15, 2007

    orders placed for delivery tomorrow include more items for planned meals (as opposed to items for general stocking) than orders placed for delivery in the more distant future, and that groceries for planned meals entail more should items... View Details
    Keywords: Martha Lagace
    • Web

    Hiring Organizations

    More Capital Friedom Partners Frontier Capital Management G Gagosian GALLO Gather Health Gauge Capital GCM Grosvenor GE Vernova Gemspring Capital Genentech General Atlantic General Catalyst View Details
    • 05 Sep 2023
    • Book

    Failing Well: How Your ‘Intelligent Failure’ Unlocks Your Full Potential

    acid deficiency. When the drug was reformulated with folic acid, it passed its efficacy trials, eventually becoming a multibillion-dollar pharmaceutical that helped thousands of lung cancer patients. How to fail intelligently Edmondson,... View Details
    Keywords: by Michael Blanding
    • 21 Apr 2009
    • First Look

    First Look: April 21, 2009

    participation decisions. Based on our experimental results, we suggest preliminary lessons for improving the design of household risk management contracts. Download the paper: http://www.hbs.edu/research/pdf/09-116.pdf Where Is the Pharmacy to the World? International... View Details
    Keywords: Martha Lagace
    • Research Summary

    Overview

    My focus is empirical financial accounting research, with particular interests in governance, valuation, M&A, and short-sellers. All three of my papers to date fall under the broad heading of “alternative governance mechanisms”—studies of how accounting information is... View Details
    Keywords: Mergers and Acquisitions; Corporate Governance; Valuation; Law
    • Research Summary

    Overview

    My focus is empirical financial accounting research, with particular interests in governance, valuation, M&A, and short-sellers. All three of my papers to date fall under the broad heading of “alternative governance mechanisms”—studies of how accounting information is... View Details
    Keywords: Mergers and Acquisitions; Corporate Governance; Valuation; Law

      Stefan H. Thomke

      Stefan Thomke (sthomke@hbs.edu), an authority on the management of innovation, is the William Barclay Harding Professor of Business Administration at Harvard Business School. He has worked with firms on product, process, and... View Details

      Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
      • February 2024
      • Article

      Representation and Extrapolation: Evidence from Clinical Trials

      By: Marcella Alsan, Maya Durvasula, Harsh Gupta, Joshua Schwartzstein and Heidi L. Williams
      This article examines the consequences and causes of low enrollment of Black patients in clinical trials. We develop a simple model of similarity-based extrapolation that predicts that evidence is more relevant for decision-making by physicians and patients when it... View Details
      Keywords: Representation; Racial Disparity; Health Testing and Trials; Race; Equality and Inequality; Innovation and Invention; Pharmaceutical Industry
      Related
      • Research Summary

      Clinical Trials as a setting for Health Policy and Management Research

      The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details

        Rohit Deshpande

        Rohit Deshpandé is a Baker Foundation Professor and Sebastian S. Kresge Professor of Marketing, Emeritus at Harvard Business School, where he has been teaching in the Advanced Management Program,... View Details

        Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
        • 25 Jul 2023
        • Research & Ideas

        Could a Business Model Help Big Pharma Save Lives and Profit?

        low-income countries, instead of zealously guarding it, cutting it off from patients and profits. The licensees then work with local governments and markets while paying the pharmaceutical company for the right to sell View Details
        Keywords: by Esther Schrader; Pharmaceutical; Pharmaceutical
        • 09 May 2024
        • Research & Ideas

        Called Back to the Office? How You Benefit from Ideas You Didn't Know You Were Missing

        knowledge sharing outside one’s core department. That is one implication of a new study about how knowledge is shared that focuses on academia, but may offer lessons for technology, pharmaceutical development, and other STEM industries.... View Details
        Keywords: by Ben Rand
        • December 2005 (Revised October 2006)
        • Case

        Pharmacy Service Improvement at CVS (A)

        CVS's retail pharmacy operations are functioning poorly and dissatisfying customers. Many customers are defecting as a result. A pharmacy service improvement team has documented the current prescription fulfillment process, its exception rates, and the problems... View Details
        Keywords: Information Technology; Performance Improvement; Business Processes; Pharmaceutical Industry; Pharmaceutical Industry; United States
        Related
        • 10 Oct 2007
        • First Look

        First Look: First Look: October 10

        Hamermesh, Faculty Chair of the Harvard Business Healthcare Initiative, discuss the barriers to personalized medicine and suggest ways to overcome them. The blockbuster model for developing drugs, the authors point out, is still what most major View Details
        Keywords: Martha Lagace

          Roberto Verganti

          Roberto Verganti is in the Technology and Operations Management Unit at Harvard Business School. He teaches Design Theory and Practice for the double degree program MS/MBA conducted jointly by the Harvard Business School and the... View Details

          Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals

            Gerald Zaltman

            *Joined Harvard Faculty: 1991
            Prior Faculty Appointments: Northwestern University, 1968-75;
            University of Pittsburgh, 1975-91

            *Doctoral Degree in Sociology Received from: The John Hopkins University;
            MBA Degree Received from: The University of... View Details

            Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
            • August 2024
            • Article

            How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?

            By: Leemore S. Dafny, Kate Ho and Edward Kong
            Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such coupons on the grounds that they are kickbacks that induce utilization, but they are commonly used by... View Details
            Keywords: Prescription Drugs; Coupons; Impact; Health Care and Treatment; Markets; Price; Spending; Pharmaceutical Industry; United States
            Related
            • Program

            Strategy for Health Care Delivery—Virtual

            Lead strategic and organizational change to generate value Improve health care quality, system delivery, and patient value Access a network of health care institutions and facilities to enhance quality and coordination of care Leverage... View Details
            Keywords: Health Care; Health Care

              Joshua D. Margolis

              Joshua Margolis is James Dinan and Elizabeth Miller Professor of Business Administration and the Unit Head for the Organizational Behavior unit. He is also Faculty Chair of the Program for Leadership Development. His research and teaching revolve around leadership... View Details

              Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals